261 related articles for article (PubMed ID: 10698808)
1. A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression.
McGrath PJ; Stewart JW; Janal MN; Petkova E; Quitkin FM; Klein DF
Am J Psychiatry; 2000 Mar; 157(3):344-50. PubMed ID: 10698808
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
Kornstein SG; Schatzberg AF; Thase ME; Yonkers KA; McCullough JP; Keitner GI; Gelenberg AJ; Davis SM; Harrison WM; Keller MB
Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861
[TBL] [Abstract][Full Text] [Related]
3. The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls.
Strober M; DeAntonio M; Schmidt-Lackner S; Pataki C; Freeman R; Rigali J; Rao U
J Clin Psychiatry; 1999 Mar; 60(3):164-9. PubMed ID: 10192591
[TBL] [Abstract][Full Text] [Related]
4. Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination?
Levitt AJ; Joffe RT; Kamil R; McIntyre R
J Clin Psychiatry; 1999 Sep; 60(9):613-6. PubMed ID: 10520980
[TBL] [Abstract][Full Text] [Related]
5. Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients.
Elliott AJ; Uldall KK; Bergam K; Russo J; Claypoole K; Roy-Byrne PP
Am J Psychiatry; 1998 Mar; 155(3):367-72. PubMed ID: 9501747
[TBL] [Abstract][Full Text] [Related]
6. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
[TBL] [Abstract][Full Text] [Related]
7. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
Fontaine R; Ontiveros A; Elie R; Kensler TT; Roberts DL; Kaplita S; Ecker JA; Faludi G
J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
[TBL] [Abstract][Full Text] [Related]
8. Reboxetine versus fluoxetine: an overview of efficacy and tolerability.
Massana J
J Clin Psychiatry; 1998; 59 Suppl 14():8-10. PubMed ID: 9818624
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression.
Agosti V; McGrath PJ
J Affect Disord; 2002 Sep; 71(1-3):113-20. PubMed ID: 12167507
[TBL] [Abstract][Full Text] [Related]
10. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
Hirschfeld RM; Russell JM; Delgado PL; Fawcett J; Friedman RA; Harrison WM; Koran LM; Miller IW; Thase ME; Howland RH; Connolly MA; Miceli RJ
J Clin Psychiatry; 1998 Dec; 59(12):669-75. PubMed ID: 9921701
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of initial antidepressant drug choice in a "real world" randomized trial.
Simon GE; Heiligenstein J; Revicki D; VonKorff M; Katon WJ; Ludman E; Grothaus L; Wagner E
Arch Fam Med; 1999; 8(4):319-25. PubMed ID: 10418538
[TBL] [Abstract][Full Text] [Related]
12. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
Keller MB; Gelenberg AJ; Hirschfeld RM; Rush AJ; Thase ME; Kocsis JH; Markowitz JC; Fawcett JA; Koran LM; Klein DN; Russell JM; Kornstein SG; McCullough JP; Davis SM; Harrison WM
J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and cost-effectiveness of antidepressant treatment in primary health care: a six-month randomised study comparing fluoxetine to imipramine.
Serrano-Blanco A; Gabarron E; Garcia-Bayo I; Soler-Vila M; Caramés E; Peñarrubia-Maria MT; Pinto-Meza A; Haro JM;
J Affect Disord; 2006 Apr; 91(2-3):153-63. PubMed ID: 16458976
[TBL] [Abstract][Full Text] [Related]
14. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.
Judd LL; Rapaport MH; Yonkers KA; Rush AJ; Frank E; Thase ME; Kupfer DJ; Plewes JM; Schettler PJ; Tollefson G
Am J Psychiatry; 2004 Oct; 161(10):1864-71. PubMed ID: 15465984
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
Hong CJ; Hu WH; Chen CC; Hsiao CC; Tsai SJ; Ruwe FJ
J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
[TBL] [Abstract][Full Text] [Related]
16. TCAs or SSRIs as initial therapy for depression?
Tyra JM; Greenawald MH
J Fam Pract; 1999 Nov; 48(11):845-6. PubMed ID: 10907616
[No Abstract] [Full Text] [Related]
17. Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial.
Taner E; Demir EY; Cosar B
Adv Ther; 2006; 23(6):974-87. PubMed ID: 17276965
[TBL] [Abstract][Full Text] [Related]
18. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
[TBL] [Abstract][Full Text] [Related]
19. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
Wheatley DP; van Moffaert M; Timmerman L; Kremer CM
J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
Lydiard RB; Stahl SM; Hertzman M; Harrison WM
J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
